ESC Premium Access

Prognostic relevance of preclinical diastolic dysfunction across left ventricular ejection fraction categories. The DAVID-Berg study

Congress Presentation

About the speaker

Doctor Mauro Gori

Papa Giovanni XXIII Hospital, Bergamo (Italy)
1 presentation
0 follower

4 more presentations in this session

State of the Art: HFmrEF - The new middle child

Speaker: Professor R. De Boer (Rotterdam, NL)

Thumbnail

Patterns and prognostic role of N-terminal pro-B-type Natriuretic Peptide in heart failure with mid-range vs. preserved vs. reduced ejection fraction

Speaker: Doctor G. Savarese (Stockholm, SE)

Thumbnail

Prognostic relevance of the 40% left ventricular ejection fraction cut-off in chronic systolic heart failure

Speaker: Doctor A. Aimo (Pisa, IT)

Thumbnail

Should we abandon EF to stratify heart failure treatment?

Speaker: Professor S. Solomon (Boston, US)

Thumbnail

Access the full session

Heart failure with mid-range and preserved ejection fraction

Speakers: Doctor M. Gori, Professor R. De Boer, Doctor G. Savarese, Doctor A. Aimo, Professor S. Solomon
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb